Context Therapeutics Ownership | Who Owns Context Therapeutics?

Overview Forecast RevenueFinancials Chart

Context Therapeutics Ownership Summary

Context Therapeutics is owned by 70.43% institutional investors, 1.45% insiders, and 28.12% retail investors. Vanguard group is the largest institutional shareholder, holding 28.20% of CNTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.52% of its assets in Context Therapeutics shares.

CNTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Context Therapeutics	70.43%	1.45%	28.12%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	4.50M	28.20%	$9.03M
Deep track capital, lp	7.42M	13.50%	$14.88M
Nextech invest	7.42M	13.50%	$14.88M
Avidity partners management lp	7.42M	13.50%	$14.88M
Great point partners	7.42M	13.50%	$14.88M
Blue owl capital lp	5.16M	9.39%	$10.35M
Blackrock	851.70K	5.33%	$1.71M
Geode capital management	618.17K	3.87%	$1.24M
Nantahala capital management	1.94M	3.52%	$3.88M
Alyeska investment group	1.94M	3.52%	$3.85M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Blue owl capital lp	5.16M	2.88%	$10.35M
Great point partners	7.42M	2.85%	$14.88M
Nextech invest	7.42M	2.50%	$14.88M
Ally bridge group (ny)	1.89M	2.25%	$3.78M
Velan capital investment management lp	1.29M	1.48%	$2.59M
Sio capital management	1.33M	0.72%	$2.66M
Avidity partners management lp	7.42M	0.63%	$14.88M
Deep track capital, lp	7.42M	0.44%	$14.88M
Affinity asset advisors	1.62M	0.37%	$3.25M
Adar1 capital management	645.16K	0.24%	$1.29M

Top Buyers

Holder	Shares	% Assets	Change
Deep track capital, lp	7.42M	0.44%	7.42M
Nextech invest	7.42M	2.50%	7.42M
Great point partners	7.42M	2.85%	7.42M
Avidity partners management lp	7.42M	0.63%	7.42M
Blue owl capital lp	5.16M	2.88%	5.16M

Top Sellers

Holder	Shares	% Assets	Change
Driehaus capital management	-	-	-2.26M
Opaleye management	-	-	-1.11M
Altium capital management lp	-	-	-360.00K
Bridgeway capital management	41.47K	0.00%	-64.34K
Exoduspoint capital management, lp	-	-	-24.75K

New Positions

Holder	Shares	% Assets	Change	Value
Great point partners	7.42M	2.85%	7.42M	$14.88M
Deep track capital, lp	7.42M	0.44%	7.42M	$14.88M
Nextech invest	7.42M	2.50%	7.42M	$14.88M
Avidity partners management lp	7.42M	0.63%	7.42M	$14.88M
Blue owl capital lp	5.16M	2.88%	5.16M	$10.35M

Sold Out

Holder	Change
Jpmorgan chase	-33.00
Wells fargo & company/mn	-116.00
Federation des caisses desjardins du quebec	-400.00
Tower research capital llc (trc)	-6.36K
Xtx topco	-10.26K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	42	23.53%	56,682,696	-0.62%	70	0.65%	21	-22.22%	10	233.33%
Jun 30, 2024	34	36.00%	57,034,586	1349.37%	103	202.42%	27	170.00%	3	50.00%
Mar 31, 2024	25	4.17%	3,935,132	10.58%	7	17.08%	10	11.11%	2	100.00%
Dec 31, 2023	24	4.35%	3,558,639	38.00%	6	29.41%	9	-10.00%	1	-
Sep 30, 2023	23	4.55%	2,578,656	15.16%	4	28.27%	10	-	1	-50.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	2.64M	3.52%	-483.00K
Franklin Biotechnology Discv A(acc)USD	2.14M	2.86%	966.80K
Franklin Biotechnology Discovery A	679.40K	0.91%	679.40K
Vanguard Institutional Extnd Mkt Idx Tr	554.82K	0.74%	-
Fidelity Extended Market Index	301.69K	0.40%	-132.25K
Belfund SICAV Belinvest Equity A USD Acc	260.00K	0.35%	-
BlackRock Extended Equity Market K	104.84K	0.14%	-45.00
Fidelity Total Market Index	99.39K	0.13%	-244.00
NT Ext Equity Mkt Idx Fd - NL	91.44K	0.12%	-
Northern Trust Extended Eq Market Idx	78.17K	0.10%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 21, 2023	Lehr Martin A.	Chief Executive Officer	Buy	$4.90K
Feb 13, 2023	Lehr Martin A.	Chief Executive Officer	Buy	$4.90K
Feb 06, 2023	Lehr Martin A.	Chief Executive Officer	Buy	$4.90K
Jan 30, 2023	Lehr Martin A.	Chief Executive Officer	Buy	$4.90K
Jan 23, 2023	Lehr Martin A.	Chief Executive Officer	Buy	$4.90K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q2	-	-
2023 Q1	6	-

CNTX Ownership FAQ

Who Owns Context Therapeutics?

Context Therapeutics shareholders are primarily institutional investors at 70.43%, followed by 1.45% insiders and 28.12% retail investors. The average institutional ownership in Context Therapeutics's industry, Biotech Stocks , is 47.04%, which Context Therapeutics exceeds.

Who owns the most shares of Context Therapeutics?

Context Therapeutics’s largest shareholders are Vanguard group (4.5M shares, 28.20%), Deep track capital, lp (7.42M shares, 13.50%), and Nextech invest (7.42M shares, 13.50%). Together, they hold 55.20% of Context Therapeutics’s total shares outstanding.

Does Blackrock own Context Therapeutics?

Yes, BlackRock owns 5.33% of Context Therapeutics, totaling 851.7K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.71M$. In the last quarter, BlackRock increased its holdings by 851.7K shares, a 100.00% change.

Who is Context Therapeutics’s biggest shareholder by percentage of total assets invested?

Blue owl capital lp is Context Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.88% of its assets in 5.16M Context Therapeutics shares, valued at 10.35M$.

Who is the top mutual fund holder of Context Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Context Therapeutics shares, with 3.52% of its total shares outstanding invested in 2.64M Context Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools